Covidien SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP

Covidien

Healthcare

Pharma and Healthcare

Positive results for life

Value system of accountability, compassion, collaboration and diversity

Medical devices and supplies, imaging solutions, and pharmaceuticals worldwide, for use in both the clinical setting and at home.

Hospitals, surgical centers, imaging centers, drug manufacturers, pharmacies, and other retailers

Innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence

Below are the Strengths in the SWOT Analysis of Covidien:

1. Diverse portfolio of products
2. One of the few global healthcare products leader
3. Commitment to social responsibility
4. Niche market leader

5. Brand name is strong in the healthcare industry

Here are the weaknesses in the Covidien SWOT Analysis:

1. Expiring patents is a concern
2.Young company compared to competitors
3.Weak history of partnerships, acquistions
4.Low debt to equity ratio is a concern

Following are the Opportunities in Covidien SWOT Analysis:

1. Geographical expansion
2.Philanthropic efforts
3.Online presence and brand building

4. Energy and Vascular business

The threats in the SWOT Analysis of Covidien are as mentioned:

1.Focus on continuous innovation
2.Recently spun off from parent company – Tyco International
3.Strong management needed to guide company through difficult period

4.Conformance to ethical and legal issues

5. Huge debt constrains management from exploring growth opportunities

Below are the top 2 Covidien competitors:

1.C.R. Bard Inc
2.Johnson & johnson